Target intelligence / Profile preview

SMIM2 antisense RNA 1 (SMIM2-AS1)

Target
SMIM2-AS1
Molecular classification
long non-coding RNA, antisense RNA, lncRNA
01

Overview

SMIM2 antisense RNA 1 (SMIM2-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 13q14.11[3][4]. It does not encode a protein but is thought to participate in gene regulation by interacting with other molecules at the RNA level[1]. The specific biological functions of SMIM2-AS1 remain unclear; however, some research suggests a role in cancer development and progression, although the mechanisms are not fully defined[1][5]. SMIM2-AS1 is not currently considered a therapeutic target, receptor, enzyme, transporter, or similar druggable entity. Key points: - SMIM2-AS1 is a non-protein-coding, long antisense RNA gene[3][4]. - It may be linked to gene regulatory roles and has been mentioned in the context of cancer susceptibility[1][5]. - There are no established drugs, mechanisms of action, or validated biomarkers associated with SMIM2-AS1 at present. - No safety concerns or therapeutic challenges are documented, reflecting its uncertain or indirect disease relevance in current literature.

Other names
C13orf44-AS1C3orf81-AS1C13orf44 antisense RNA 1 (non-protein coding)SMIM2 antisense RNA 1 (non-protein coding)SMIM2-AS1
02

Biological functions

gene regulationpossible involvement in cancer biology (under active research)
03

Disease associations

Cancer (suggested association)Other (uncertain, as biological roles remain unclear)

Beyond the preview

Go deeper on SMIM2 antisense RNA 1 (SMIM2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMIM2 antisense RNA 1 (SMIM2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call